Neurocrine Biosciences (NBIX) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $142.25 --0%
Revenue Growth %: +30.8%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +30.8%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.21), in-line with the analyst estimate of ($0.21).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Oppenheimer Starts Teva Pharma (TEVA) at Outperform
- Nike (NKE) PT Raised to $55 at BTIG
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
